Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

First-in-Class ROR1 Small Molecule Inhibitor (KAN0439834) Downregulated Wnt-Canonical and Non-Canonical Signaling Pathways and Induced Apoptosis of CLL Cells

Mohammad Hojjat-Farsangi, PhD, Ali Moshfegh, PhD, Amir Hossein Daneshmanesh, MD PhD, Jan Vågberg, Byström Styrbjörn, Johan Schultz, Elisabeth Olsson, Charlotta Löfberg, Carina Norström, Martin Norin, Thomas Olin, PhD, Anders Österborg, MD PhD, Håkan Mellstedt, MD PhD

Blood (2015) 126 (23): 2912.

https://doi.org/10.1182/blood.V126.23.2912.2912

Published: 2015

Journal Articles

Monoclonal Antibody Against ROR1 in Chronic Lymphocytic Leukemia Cells Induced Apoptosis Via PI3-Kinase/AKT/CREB Pathway

Amir Hossein Daneshmanesh, MD, PhD, Mohammad Hojjat-Farsangi, PhD, Asa Sandin, PhD, Abdul Salam Khan, Msc, Ali Moshfegh, PhD, Mahmood Jeddi-Tehrani, PhD, Anders Österborg, MD, PhD, Håkan Mellstedt, MD, PhD

Blood (2012) 120 (21): 1769.

https://doi.org/10.1182/blood.V120.21.1769.1769

Published: 2012

Journal Articles

ROR1 Isoforms Are Constitutively Phosphorylated in Chronic Lymphocytic Leukemia (CLL) - a Survival Factor for CLL Cells

Hakan Mellstedt, MD, PhD., Mohammad Hojjat-Farsangi, PhD, Ladan Mansouri, MD, Anders Osterborg, MD, PhD, Hodjattallah Rabbani, PhD

Blood (2011) 118 (21): 1778.

https://doi.org/10.1182/blood.V118.21.1778.1778

Published: 2011

Journal Articles

Patients with Chronic Lymphocyte Leukemia (CLL) Have Naturally Occurring Antibodies Against the Receptor Tyrosine Kinase (ROR1)

Mohammad Hojjat-Farsangi, PhD, Fariba Mozaffari, Ph.D, Amir Hossein Daneshmanesh, MD, Ph.D, Anders Osterborg, MD, PhD, Fazel Shokri, Ph.D, Håkan Mellstedt, MD, Ph.D

Blood (2011) 118 (21): 1771.

https://doi.org/10.1182/blood.V118.21.1771.1771

Published: 2011

Journal Articles

Ror1 Targeting Monoclonal Antibodies Induced Apoptosis of Chronic Lymphocytic Leukemia Cells– A Potential Novel Therapeutic Approach

Hodjattallah Rabbani, PhD, Amir Hossein Daneshmanesh, MD, Abdul Salam Khan, MSc, Mohammad Hojjat-Farsangi, PhD, Mahmood Jeddi-Tehrani, PhD, Mohammad Mehdi Akhondi, PhD, Anders Österborg, MD, PhD, Fazel Shokri, PhD, Håakan Mellstedt, MD, PhD

Blood (2010) 116 (21): 916.

https://doi.org/10.1182/blood.V116.21.916.916

Published: 2010

NARROW

First-in-Class ROR1 Small Molecule Inhibitor (KAN0439834) Downregulated Wnt-Canonical and Non-Canonical Signaling Pathways and Induced Apoptosis of CLL Cells

Monoclonal Antibody Against ROR1 in Chronic Lymphocytic Leukemia Cells Induced Apoptosis Via PI3-Kinase/AKT/CREB Pathway

ROR1 Isoforms Are Constitutively Phosphorylated in Chronic Lymphocytic Leukemia (CLL) - a Survival Factor for CLL Cells

Patients with Chronic Lymphocyte Leukemia (CLL) Have Naturally Occurring Antibodies Against the Receptor Tyrosine Kinase (ROR1)

Ror1 Targeting Monoclonal Antibodies Induced Apoptosis of Chronic Lymphocytic Leukemia Cells– A Potential Novel Therapeutic Approach

Email alerts

ASH Publications

American Society of Hematology

First-in-Class ROR1 Small Molecule Inhibitor (KAN0439834) Downregulated Wnt-Canonical and Non-Canonical Signaling Pathways and Induced Apoptosis of CLL Cells

Monoclonal Antibody Against ROR1 in Chronic Lymphocytic Leukemia Cells Induced Apoptosis Via PI3-Kinase/AKT/CREB Pathway

ROR1 Isoforms Are Constitutively Phosphorylated in Chronic Lymphocytic Leukemia (CLL) - a Survival Factor for CLL Cells

Patients with Chronic Lymphocyte Leukemia (CLL) Have Naturally Occurring Antibodies Against the Receptor Tyrosine Kinase (ROR1)

Ror1 Targeting Monoclonal Antibodies Induced Apoptosis of Chronic Lymphocytic Leukemia Cells– A Potential Novel Therapeutic Approach

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only